Some study found that a novel deletion of MUC17 at 7q22.1 affected prognosis of biliary tract cancer patients which have negative effects on mutated genes including TP53, KRAS, SMAD4, NF1, ARID1A, PBRM1, and ATR30. This evidence concerns the gene KRAS and biliary tract neoplasm.